Clinical Trial Update: Comparison of Antithrombotic Treatments After Aortic Valve Replacement. Rivaroxaban: A New Antithrombotic Treatment for Patients With Mechanical Prosthetic Aortic Heart Valve. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rivaroxaban as an antithrombotic after mechanical aortic valve replacement was terminated, with no results summarized in the provided…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Heart Valve Prosthesis Implantation

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Aortic Valve Disease, Heart Valve Prosthesis Implantation | Phase 2 | Status: TERMINATED